2
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

2
U.S. (TOLL FREE)
+1 (315) 215-3225
Global COPD and Asthma Devices Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-14C7239
Home | Market Reports | Health| Health Conditions| Respiratory Conditions
Global COPD and Asthma Devices Market Insights and Forecast to 2028
BUY CHAPTERS

Global COPD and Asthma Devices Market Research Report 2025

Code: QYRE-Auto-14C7239
Report
August 2025
Pages:88
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

COPD and Asthma Devices Market

The global market for COPD and Asthma Devices was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Chronic obstructive pulmonary disease (COPD) and asthma devices are useful in inhalation therapy and assist in drug delivery by converting drug suspensions or solutions to aerosolized particles.
The need for urgency in medication and portability of the drug delivery devices will drive the growth for COPD and Asthma devices.

Report Scope

This report aims to provide a comprehensive presentation of the global market for COPD and Asthma Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding COPD and Asthma Devices.
The COPD and Asthma Devices market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global COPD and Asthma Devices market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the COPD and Asthma Devices manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of COPD and Asthma Devices Market Report

Report Metric Details
Report Name COPD and Asthma Devices Market
Segment by Type
  • Metered Dose Inhalers (MDI)
  • Drug Powder Inhalers (DPI)
  • Soft Mist Inhalers
  • Jet Nebulizers
  • Ultrasonic Nebulizers
  • Others
Segment by Application
  • Hospitals
  • Clinics
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc, AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc, Sunovion Pharmaceuticals Inc, GF Healthcare Products, Smith Medicals, Lincare Holdings Inc, Baxter International
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of COPD and Asthma Devices manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of COPD and Asthma Devices in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the COPD and Asthma Devices Market report?

Ans: The main players in the COPD and Asthma Devices Market are GlaxoSmithKline Plc, Novartis AG, Merck & Co., Inc, AstraZeneca Plc, Philips Healthcare, 3M Health Care, Allied Healthcare Products Inc, Sunovion Pharmaceuticals Inc, GF Healthcare Products, Smith Medicals, Lincare Holdings Inc, Baxter International

What are the Application segmentation covered in the COPD and Asthma Devices Market report?

Ans: The Applications covered in the COPD and Asthma Devices Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the COPD and Asthma Devices Market report?

Ans: The Types covered in the COPD and Asthma Devices Market report are Metered Dose Inhalers (MDI), Drug Powder Inhalers (DPI), Soft Mist Inhalers, Jet Nebulizers, Ultrasonic Nebulizers, Others

1 COPD and Asthma Devices Market Overview
1.1 Product Definition
1.2 COPD and Asthma Devices by Type
1.2.1 Global COPD and Asthma Devices Market Value Comparison by Type (2024 VS 2031)
1.2.2 Metered Dose Inhalers (MDI)
1.2.3 Drug Powder Inhalers (DPI)
1.2.4 Soft Mist Inhalers
1.2.5 Jet Nebulizers
1.2.6 Ultrasonic Nebulizers
1.2.7 Others
1.3 COPD and Asthma Devices by Application
1.3.1 Global COPD and Asthma Devices Market Value by Application (2024 VS 2031)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global COPD and Asthma Devices Market Size Estimates and Forecasts
1.4.1 Global COPD and Asthma Devices Revenue 2020-2031
1.4.2 Global COPD and Asthma Devices Sales 2020-2031
1.4.3 Global COPD and Asthma Devices Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 COPD and Asthma Devices Market Competition by Manufacturers
2.1 Global COPD and Asthma Devices Sales Market Share by Manufacturers (2020-2025)
2.2 Global COPD and Asthma Devices Revenue Market Share by Manufacturers (2020-2025)
2.3 Global COPD and Asthma Devices Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of COPD and Asthma Devices, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of COPD and Asthma Devices, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of COPD and Asthma Devices, Product Type & Application
2.7 Global Key Manufacturers of COPD and Asthma Devices, Date of Enter into This Industry
2.8 Global COPD and Asthma Devices Market Competitive Situation and Trends
2.8.1 Global COPD and Asthma Devices Market Concentration Rate
2.8.2 The Global 5 and 10 Largest COPD and Asthma Devices Players Market Share by Revenue
2.8.3 Global COPD and Asthma Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global COPD and Asthma Devices Market Scenario by Region
3.1 Global COPD and Asthma Devices Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global COPD and Asthma Devices Sales by Region: 2020-2031
3.2.1 Global COPD and Asthma Devices Sales by Region: 2020-2025
3.2.2 Global COPD and Asthma Devices Sales by Region: 2026-2031
3.3 Global COPD and Asthma Devices Revenue by Region: 2020-2031
3.3.1 Global COPD and Asthma Devices Revenue by Region: 2020-2025
3.3.2 Global COPD and Asthma Devices Revenue by Region: 2026-2031
3.4 North America COPD and Asthma Devices Market Facts & Figures by Country
3.4.1 North America COPD and Asthma Devices Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America COPD and Asthma Devices Sales by Country (2020-2031)
3.4.3 North America COPD and Asthma Devices Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe COPD and Asthma Devices Market Facts & Figures by Country
3.5.1 Europe COPD and Asthma Devices Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe COPD and Asthma Devices Sales by Country (2020-2031)
3.5.3 Europe COPD and Asthma Devices Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific COPD and Asthma Devices Market Facts & Figures by Region
3.6.1 Asia Pacific COPD and Asthma Devices Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific COPD and Asthma Devices Sales by Region (2020-2031)
3.6.3 Asia Pacific COPD and Asthma Devices Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America COPD and Asthma Devices Market Facts & Figures by Country
3.7.1 Latin America COPD and Asthma Devices Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America COPD and Asthma Devices Sales by Country (2020-2031)
3.7.3 Latin America COPD and Asthma Devices Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa COPD and Asthma Devices Market Facts & Figures by Country
3.8.1 Middle East and Africa COPD and Asthma Devices Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa COPD and Asthma Devices Sales by Country (2020-2031)
3.8.3 Middle East and Africa COPD and Asthma Devices Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global COPD and Asthma Devices Sales by Type (2020-2031)
4.1.1 Global COPD and Asthma Devices Sales by Type (2020-2025)
4.1.2 Global COPD and Asthma Devices Sales by Type (2026-2031)
4.1.3 Global COPD and Asthma Devices Sales Market Share by Type (2020-2031)
4.2 Global COPD and Asthma Devices Revenue by Type (2020-2031)
4.2.1 Global COPD and Asthma Devices Revenue by Type (2020-2025)
4.2.2 Global COPD and Asthma Devices Revenue by Type (2026-2031)
4.2.3 Global COPD and Asthma Devices Revenue Market Share by Type (2020-2031)
4.3 Global COPD and Asthma Devices Price by Type (2020-2031)
5 Segment by Application
5.1 Global COPD and Asthma Devices Sales by Application (2020-2031)
5.1.1 Global COPD and Asthma Devices Sales by Application (2020-2025)
5.1.2 Global COPD and Asthma Devices Sales by Application (2026-2031)
5.1.3 Global COPD and Asthma Devices Sales Market Share by Application (2020-2031)
5.2 Global COPD and Asthma Devices Revenue by Application (2020-2031)
5.2.1 Global COPD and Asthma Devices Revenue by Application (2020-2025)
5.2.2 Global COPD and Asthma Devices Revenue by Application (2026-2031)
5.2.3 Global COPD and Asthma Devices Revenue Market Share by Application (2020-2031)
5.3 Global COPD and Asthma Devices Price by Application (2020-2031)
6 Key Companies Profiled
6.1 GlaxoSmithKline Plc
6.1.1 GlaxoSmithKline Plc Company Information
6.1.2 GlaxoSmithKline Plc Description and Business Overview
6.1.3 GlaxoSmithKline Plc COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.1.4 GlaxoSmithKline Plc COPD and Asthma Devices Product Portfolio
6.1.5 GlaxoSmithKline Plc Recent Developments/Updates
6.2 Novartis AG
6.2.1 Novartis AG Company Information
6.2.2 Novartis AG Description and Business Overview
6.2.3 Novartis AG COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Novartis AG COPD and Asthma Devices Product Portfolio
6.2.5 Novartis AG Recent Developments/Updates
6.3 Merck & Co., Inc
6.3.1 Merck & Co., Inc Company Information
6.3.2 Merck & Co., Inc Description and Business Overview
6.3.3 Merck & Co., Inc COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck & Co., Inc COPD and Asthma Devices Product Portfolio
6.3.5 Merck & Co., Inc Recent Developments/Updates
6.4 AstraZeneca Plc
6.4.1 AstraZeneca Plc Company Information
6.4.2 AstraZeneca Plc Description and Business Overview
6.4.3 AstraZeneca Plc COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.4.4 AstraZeneca Plc COPD and Asthma Devices Product Portfolio
6.4.5 AstraZeneca Plc Recent Developments/Updates
6.5 Philips Healthcare
6.5.1 Philips Healthcare Company Information
6.5.2 Philips Healthcare Description and Business Overview
6.5.3 Philips Healthcare COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Philips Healthcare COPD and Asthma Devices Product Portfolio
6.5.5 Philips Healthcare Recent Developments/Updates
6.6 3M Health Care
6.6.1 3M Health Care Company Information
6.6.2 3M Health Care Description and Business Overview
6.6.3 3M Health Care COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.6.4 3M Health Care COPD and Asthma Devices Product Portfolio
6.6.5 3M Health Care Recent Developments/Updates
6.7 Allied Healthcare Products Inc
6.7.1 Allied Healthcare Products Inc Company Information
6.7.2 Allied Healthcare Products Inc Description and Business Overview
6.7.3 Allied Healthcare Products Inc COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Allied Healthcare Products Inc COPD and Asthma Devices Product Portfolio
6.7.5 Allied Healthcare Products Inc Recent Developments/Updates
6.8 Sunovion Pharmaceuticals Inc
6.8.1 Sunovion Pharmaceuticals Inc Company Information
6.8.2 Sunovion Pharmaceuticals Inc Description and Business Overview
6.8.3 Sunovion Pharmaceuticals Inc COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Sunovion Pharmaceuticals Inc COPD and Asthma Devices Product Portfolio
6.8.5 Sunovion Pharmaceuticals Inc Recent Developments/Updates
6.9 GF Healthcare Products
6.9.1 GF Healthcare Products Company Information
6.9.2 GF Healthcare Products Description and Business Overview
6.9.3 GF Healthcare Products COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.9.4 GF Healthcare Products COPD and Asthma Devices Product Portfolio
6.9.5 GF Healthcare Products Recent Developments/Updates
6.10 Smith Medicals
6.10.1 Smith Medicals Company Information
6.10.2 Smith Medicals Description and Business Overview
6.10.3 Smith Medicals COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Smith Medicals COPD and Asthma Devices Product Portfolio
6.10.5 Smith Medicals Recent Developments/Updates
6.11 Lincare Holdings Inc
6.11.1 Lincare Holdings Inc Company Information
6.11.2 Lincare Holdings Inc Description and Business Overview
6.11.3 Lincare Holdings Inc COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Lincare Holdings Inc COPD and Asthma Devices Product Portfolio
6.11.5 Lincare Holdings Inc Recent Developments/Updates
6.12 Baxter International
6.12.1 Baxter International Company Information
6.12.2 Baxter International Description and Business Overview
6.12.3 Baxter International COPD and Asthma Devices Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Baxter International COPD and Asthma Devices Product Portfolio
6.12.5 Baxter International Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 COPD and Asthma Devices Industry Chain Analysis
7.2 COPD and Asthma Devices Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 COPD and Asthma Devices Production Mode & Process Analysis
7.4 COPD and Asthma Devices Sales and Marketing
7.4.1 COPD and Asthma Devices Sales Channels
7.4.2 COPD and Asthma Devices Distributors
7.5 COPD and Asthma Devices Customer Analysis
8 COPD and Asthma Devices Market Dynamics
8.1 COPD and Asthma Devices Industry Trends
8.2 COPD and Asthma Devices Market Drivers
8.3 COPD and Asthma Devices Market Challenges
8.4 COPD and Asthma Devices Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global COPD and Asthma Devices Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global COPD and Asthma Devices Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global COPD and Asthma Devices Market Competitive Situation by Manufacturers in 2024
 Table 4. Global COPD and Asthma Devices Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global COPD and Asthma Devices Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global COPD and Asthma Devices Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global COPD and Asthma Devices Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market COPD and Asthma Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of COPD and Asthma Devices, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of COPD and Asthma Devices, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of COPD and Asthma Devices, Product Type & Application
 Table 12. Global Key Manufacturers of COPD and Asthma Devices, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global COPD and Asthma Devices by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in COPD and Asthma Devices as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global COPD and Asthma Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global COPD and Asthma Devices Sales by Region (2020-2025) & (K Units)
 Table 18. Global COPD and Asthma Devices Sales Market Share by Region (2020-2025)
 Table 19. Global COPD and Asthma Devices Sales by Region (2026-2031) & (K Units)
 Table 20. Global COPD and Asthma Devices Sales Market Share by Region (2026-2031)
 Table 21. Global COPD and Asthma Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global COPD and Asthma Devices Revenue Market Share by Region (2020-2025)
 Table 23. Global COPD and Asthma Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global COPD and Asthma Devices Revenue Market Share by Region (2026-2031)
 Table 25. North America COPD and Asthma Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America COPD and Asthma Devices Sales by Country (2020-2025) & (K Units)
 Table 27. North America COPD and Asthma Devices Sales by Country (2026-2031) & (K Units)
 Table 28. North America COPD and Asthma Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America COPD and Asthma Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe COPD and Asthma Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe COPD and Asthma Devices Sales by Country (2020-2025) & (K Units)
 Table 32. Europe COPD and Asthma Devices Sales by Country (2026-2031) & (K Units)
 Table 33. Europe COPD and Asthma Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe COPD and Asthma Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific COPD and Asthma Devices Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific COPD and Asthma Devices Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific COPD and Asthma Devices Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific COPD and Asthma Devices Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific COPD and Asthma Devices Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America COPD and Asthma Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America COPD and Asthma Devices Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America COPD and Asthma Devices Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America COPD and Asthma Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America COPD and Asthma Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa COPD and Asthma Devices Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa COPD and Asthma Devices Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa COPD and Asthma Devices Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa COPD and Asthma Devices Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa COPD and Asthma Devices Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global COPD and Asthma Devices Sales (K Units) by Type (2020-2025)
 Table 51. Global COPD and Asthma Devices Sales (K Units) by Type (2026-2031)
 Table 52. Global COPD and Asthma Devices Sales Market Share by Type (2020-2025)
 Table 53. Global COPD and Asthma Devices Sales Market Share by Type (2026-2031)
 Table 54. Global COPD and Asthma Devices Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global COPD and Asthma Devices Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global COPD and Asthma Devices Revenue Market Share by Type (2020-2025)
 Table 57. Global COPD and Asthma Devices Revenue Market Share by Type (2026-2031)
 Table 58. Global COPD and Asthma Devices Price (USD/Unit) by Type (2020-2025)
 Table 59. Global COPD and Asthma Devices Price (USD/Unit) by Type (2026-2031)
 Table 60. Global COPD and Asthma Devices Sales (K Units) by Application (2020-2025)
 Table 61. Global COPD and Asthma Devices Sales (K Units) by Application (2026-2031)
 Table 62. Global COPD and Asthma Devices Sales Market Share by Application (2020-2025)
 Table 63. Global COPD and Asthma Devices Sales Market Share by Application (2026-2031)
 Table 64. Global COPD and Asthma Devices Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global COPD and Asthma Devices Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global COPD and Asthma Devices Revenue Market Share by Application (2020-2025)
 Table 67. Global COPD and Asthma Devices Revenue Market Share by Application (2026-2031)
 Table 68. Global COPD and Asthma Devices Price (USD/Unit) by Application (2020-2025)
 Table 69. Global COPD and Asthma Devices Price (USD/Unit) by Application (2026-2031)
 Table 70. GlaxoSmithKline Plc Company Information
 Table 71. GlaxoSmithKline Plc Description and Business Overview
 Table 72. GlaxoSmithKline Plc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 73. GlaxoSmithKline Plc COPD and Asthma Devices Product
 Table 74. GlaxoSmithKline Plc Recent Developments/Updates
 Table 75. Novartis AG Company Information
 Table 76. Novartis AG Description and Business Overview
 Table 77. Novartis AG COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 78. Novartis AG COPD and Asthma Devices Product
 Table 79. Novartis AG Recent Developments/Updates
 Table 80. Merck & Co., Inc Company Information
 Table 81. Merck & Co., Inc Description and Business Overview
 Table 82. Merck & Co., Inc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 83. Merck & Co., Inc COPD and Asthma Devices Product
 Table 84. Merck & Co., Inc Recent Developments/Updates
 Table 85. AstraZeneca Plc Company Information
 Table 86. AstraZeneca Plc Description and Business Overview
 Table 87. AstraZeneca Plc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 88. AstraZeneca Plc COPD and Asthma Devices Product
 Table 89. AstraZeneca Plc Recent Developments/Updates
 Table 90. Philips Healthcare Company Information
 Table 91. Philips Healthcare Description and Business Overview
 Table 92. Philips Healthcare COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 93. Philips Healthcare COPD and Asthma Devices Product
 Table 94. Philips Healthcare Recent Developments/Updates
 Table 95. 3M Health Care Company Information
 Table 96. 3M Health Care Description and Business Overview
 Table 97. 3M Health Care COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 98. 3M Health Care COPD and Asthma Devices Product
 Table 99. 3M Health Care Recent Developments/Updates
 Table 100. Allied Healthcare Products Inc Company Information
 Table 101. Allied Healthcare Products Inc Description and Business Overview
 Table 102. Allied Healthcare Products Inc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 103. Allied Healthcare Products Inc COPD and Asthma Devices Product
 Table 104. Allied Healthcare Products Inc Recent Developments/Updates
 Table 105. Sunovion Pharmaceuticals Inc Company Information
 Table 106. Sunovion Pharmaceuticals Inc Description and Business Overview
 Table 107. Sunovion Pharmaceuticals Inc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 108. Sunovion Pharmaceuticals Inc COPD and Asthma Devices Product
 Table 109. Sunovion Pharmaceuticals Inc Recent Developments/Updates
 Table 110. GF Healthcare Products Company Information
 Table 111. GF Healthcare Products Description and Business Overview
 Table 112. GF Healthcare Products COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 113. GF Healthcare Products COPD and Asthma Devices Product
 Table 114. GF Healthcare Products Recent Developments/Updates
 Table 115. Smith Medicals Company Information
 Table 116. Smith Medicals Description and Business Overview
 Table 117. Smith Medicals COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 118. Smith Medicals COPD and Asthma Devices Product
 Table 119. Smith Medicals Recent Developments/Updates
 Table 120. Lincare Holdings Inc Company Information
 Table 121. Lincare Holdings Inc Description and Business Overview
 Table 122. Lincare Holdings Inc COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 123. Lincare Holdings Inc COPD and Asthma Devices Product
 Table 124. Lincare Holdings Inc Recent Developments/Updates
 Table 125. Baxter International Company Information
 Table 126. Baxter International Description and Business Overview
 Table 127. Baxter International COPD and Asthma Devices Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
 Table 128. Baxter International COPD and Asthma Devices Product
 Table 129. Baxter International Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. COPD and Asthma Devices Distributors List
 Table 133. COPD and Asthma Devices Customers List
 Table 134. COPD and Asthma Devices Market Trends
 Table 135. COPD and Asthma Devices Market Drivers
 Table 136. COPD and Asthma Devices Market Challenges
 Table 137. COPD and Asthma Devices Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of COPD and Asthma Devices
 Figure 2. Global COPD and Asthma Devices Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global COPD and Asthma Devices Market Share by Type: 2024 & 2031
 Figure 4. Metered Dose Inhalers (MDI) Product Picture
 Figure 5. Drug Powder Inhalers (DPI) Product Picture
 Figure 6. Soft Mist Inhalers Product Picture
 Figure 7. Jet Nebulizers Product Picture
 Figure 8. Ultrasonic Nebulizers Product Picture
 Figure 9. Others Product Picture
 Figure 10. Global COPD and Asthma Devices Market Value by Application (2020-2031) & (US$ Million)
 Figure 11. Global COPD and Asthma Devices Market Share by Application: 2024 & 2031
 Figure 12. Hospitals
 Figure 13. Clinics
 Figure 14. Others
 Figure 15. Global COPD and Asthma Devices Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global COPD and Asthma Devices Market Size (2020-2031) & (US$ Million)
 Figure 17. Global COPD and Asthma Devices Sales (2020-2031) & (K Units)
 Figure 18. Global COPD and Asthma Devices Average Price (USD/Unit) & (2020-2031)
 Figure 19. COPD and Asthma Devices Report Years Considered
 Figure 20. COPD and Asthma Devices Sales Share by Manufacturers in 2024
 Figure 21. Global COPD and Asthma Devices Revenue Share by Manufacturers in 2024
 Figure 22. Global 5 and 10 Largest COPD and Asthma Devices Players: Market Share by Revenue in COPD and Asthma Devices in 2024
 Figure 23. COPD and Asthma Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 24. Global COPD and Asthma Devices Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 25. North America COPD and Asthma Devices Sales Market Share by Country (2020-2031)
 Figure 26. North America COPD and Asthma Devices Revenue Market Share by Country (2020-2031)
 Figure 27. U.S. COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. Canada COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. Europe COPD and Asthma Devices Sales Market Share by Country (2020-2031)
 Figure 30. Europe COPD and Asthma Devices Revenue Market Share by Country (2020-2031)
 Figure 31. Germany COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. France COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. U.K. COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Italy COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Russia COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Asia Pacific COPD and Asthma Devices Sales Market Share by Region (2020-2031)
 Figure 37. Asia Pacific COPD and Asthma Devices Revenue Market Share by Region (2020-2031)
 Figure 38. China COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Japan COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. South Korea COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. India COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Australia COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Taiwan COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Indonesia COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Thailand COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Malaysia COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Philippines COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Latin America COPD and Asthma Devices Sales Market Share by Country (2020-2031)
 Figure 49. Latin America COPD and Asthma Devices Revenue Market Share by Country (2020-2031)
 Figure 50. Mexico COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Brazil COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Argentina COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Middle East and Africa COPD and Asthma Devices Sales Market Share by Country (2020-2031)
 Figure 54. Middle East and Africa COPD and Asthma Devices Revenue Market Share by Country (2020-2031)
 Figure 55. Turkey COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 56. Saudi Arabia COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 57. UAE COPD and Asthma Devices Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 58. Global Sales Market Share of COPD and Asthma Devices by Type (2020-2031)
 Figure 59. Global Revenue Market Share of COPD and Asthma Devices by Type (2020-2031)
 Figure 60. Global COPD and Asthma Devices Price (USD/Unit) by Type (2020-2031)
 Figure 61. Global Sales Market Share of COPD and Asthma Devices by Application (2020-2031)
 Figure 62. Global Revenue Market Share of COPD and Asthma Devices by Application (2020-2031)
 Figure 63. Global COPD and Asthma Devices Price (USD/Unit) by Application (2020-2031)
 Figure 64. COPD and Asthma Devices Value Chain
 Figure 65. Channels of Distribution (Direct Vs Distribution)
 Figure 66. Bottom-up and Top-down Approaches for This Report
 Figure 67. Data Triangulation
 Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

RELATED REPORTS

Global Inhaled Treatment for Asthma and COPD Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-19Y19888
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Oxygen Inhaler Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-11D3386
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-26D2937
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Bronchiectasis Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-18E6080
Mon Sep 08 00:00:00 UTC 2025

Add to Cart